Perspective Therapeutics, Inc. — Director's Dealing 2019

Nov 21, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Isoray, Inc. (ISR)
CIK: 0000728387
Period of Report: 2019-11-20

Reporting Person: Krachon Michael (VP of Sales & Marketing)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-20	Common stock	P	50000	$0.3899	Acquired	50000	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock	55000	Direct